Edition:
United States

ProQR Therapeutics NV (PRQR.OQ)

PRQR.OQ on NASDAQ Stock Exchange Global Market

12.48USD
2:35pm EST
Change (% chg)

$-0.13 (-1.03%)
Prev Close
$12.61
Open
$12.56
Day's High
$12.63
Day's Low
$12.35
Volume
27,329
Avg. Vol
101,058
52-wk High
$24.00
52-wk Low
$2.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.96 -0.179
Jun '18 0.97 -0.230
Mar '18 0.50 -0.334
FY 2017 Dec '17 0.51 -0.393
Sep '17 0.33 -0.416
Jun '17 0.26 -0.474
Mar '17 0.39 -0.446
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 0.90 1.60 0.00 --
Quarter Ending Jun-19 3 0.63 1.10 0.00 --
Year Ending Dec-19 5 3.84 7.50 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 4 -0.31 -0.25 -0.39 --
Quarter Ending Jun-19 4 -0.33 -0.30 -0.40 --
Year Ending Dec-19 5 -1.28 -1.05 -1.59 -1.53
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta -- 1.08 0.90
Price to Sales (TTM) 79.24 49.51 6.29
Price to Book (MRQ) 2.60 10.14 5.26
Price to Tangible Book (MRQ) 2.61 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 54.62 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.01 206.16 12.76
Sales (TTM) vs TTM 1 Yr. Ago -64.75 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.03 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago -24.00 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 8.22 3.50 3.08
LT Debt to Equity (MRQ) 16.54 18.65 11.38
Total Debt to Equity (MRQ) 16.54 31.33 16.12
Interest Coverage (TTM) -- -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -3,241.64 -- --
EBITD - 5 Yr. Avg -- -110.41 12.87
Operating Margin (TTM) -3,331.95 -184.63 6.19
Operating Margin - 5 Yr. Avg. -- -126.89 8.31
Pre-Tax Margin (TTM) -3,376.41 -175.33 7.15
Pre-Tax Margin - 5 Yr. Avg. -- -132.69 8.61
Net Profit Margin (TTM) -3,376.57 -182.03 3.29
Net Profit Margin - 5 Yr. Avg. -- -137.08 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 10,657 7,654,547 842,388,263
Net Income/Employee (TTM) -359,831 562,105 99,841,601
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.02 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -61.65 6.39 11.06
Return on Assets - 5 Yr. Avg. -- 5.47 12.20
Return on Investment (TTM) -68.51 8.92 14.45
Return on Investment - 5 Yr. Avg. -- 6.78 15.87
Return on Equity (TTM) -75.74 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -43.49 150.71 --
EPS (TTM) % -87.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ProQR Therapeutics NV

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -13.89 -16.86 11 99
13 Week -10.58 -14.93 31 95
26 Week -4.12 -11.41 47 98
52 Week -34.87 -44.80 27 72
YTD -5.10 -16.66 40 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.16%
# of Holders: 86
Total Shares Held: 29,076,305
3 Mo. Net Change: 5,130,206
# New Positions: 44
# Closed Positions: 7
# Increased Positions: 59
# Reduced Positions: 24
# Net Buyers: 35
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.